AtriCure (NSDQ:ATRC) said today it launched and enrolled the 1st patient in the Frost trial which aims to examine the use of its CryoIce system designed for the cryoablation of peripheral nerves for the temporary management of post-operative pain. The trial is slated to enroll up to 100 patients to explore the use of cryoanalgesia in addition […]
AtriCure Inc.
AtriCure preps $150m offering
AtriCure (NSDQ:ATRC) registered for a securities offering worth $150 million that could bring in another $115 million for some of its stockholders in a secondary offering. West Chester, Ohio-based AtriCure said its portion of the flotation could include common stock, preferred stock, debt securities, warrants or depositary shares and units. The company won’t get any proceeds from the secondary offering […]
AtriCure wins FDA 510(k) for AtriClip Pro2 LAA device
AtriCure (NSDQ:ATRC) said today it won 510(k) clearance for its AtriClip Pro2 left atrial appendage exclusion system designed to occlude the LAA during minimally-invasive surgical procedures. The AtriClip Pro2 system is designed with an ambidextrous locking and trigger-style clip closing mechanism, the West Chester, Ohio-based company said, as well as handle-based active articulation levers and a […]
FDA clears AtriCure’s CryoForm cryoablation probe
AtriCure (NSDQ:ATRC) said yesterday it won FDA 510(k) clearance for its CryoForm cryoablation probe designed for use in cardiac ablation procedures, such as atrial fibrillation. The CryoForm is designed with the ability to remove heat and actively defrost, which allows the operator to safely detach the device while maintaining internal tissue’s frozen state, the West Chester, Ohio-based […]
AtriCure launches AtriClip trial
AtriCure (NSDQ:ATRC) said today that it’s launching a clinical trial of its AtriClip left atrial appendage closure device, aiming to show whether the device reduces the incidence of post-operative atrial fibrillation after cardiac surgery to repair a structural heart defect. West Chester, Ohio-based AtriCure said the 1st patient in the 1-year Atlas trial was enrolled at PinnacleHealth […]
AtriCure wins Japanese regulatory nod for AtriClip
AtriCure (NSDQ:ATRC) said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its AtriClip line of products designed for the occlusion of the left atrial appendage. The approval was achieved through the aid of the company’s Japanese distributor Century Medical Inc, the West Chester, Ohio-based company said. “We are excited to […]
AtriCure launches study of combined surgical, catheter afib ablations
AtriCure (NSDQ:ATRC) said today that it launched a clinical trial comparing a combined ablation approach with catheter ablation in patients with persistent atrial fibrillation. The 1st subject in the more-than-200-patient CEASE AF study was treated by co-principal investigator Dr. Nicolas Doll of the Sana Heart Center in Stuttgart, Germany, West Chester, Ohio-based AtriCure said. The trial is designed to compare […]
AtriCure closes $99m nContact buy
AtriCure (NSDQ:ATRC) said yesterday that it closed the $99 million cash-and-stock buyout of cardiac ablation device maker nContact. Morrisville, N.C.-based nContact makes a system that’s designed to combine vacuum suction, perfusion and radiofrequency ablation to improve contact between cardiac tissue and the device. The company is running a U.S. investigational device exemption trial, comparing its Convergent procedure using the […]
AtriCure picks up MIS cardiac company nContact
AtriCure (NSDQ:ATRC) said yesterday it bought cardiac-focused medical device developer nContact for approximately $99 million in shares of common stock and up front cash. The sale was funded with an upfront payment of approximately 3.7 million shares of AtriCure at $24.60 per share and $8 million in cash up front. The purchase also includes up to $50 million […]
AtriCure launches CryoForm cryoablation probe
AtriCure (NSDQ:ATRC) said today it launched the CryoForm cryoablation probe for use in cardiac ablation procedures, such as atrial fibrillation. The CryoForm includes the ability to remove heat and actively defrost, which allows the operator to safely detach the device while maintaining internal tissue’s frozen state, the West Chester, Ohio-based company said. “We are excited to […]
Atricure gains on earnings, rev beat
AtriCure (NSDQ:ATRC) announced its 2nd quarter earnings, beating street estimates for both earnings and revenue. Atricure saw losses of $4.9 million on total sales of $32.6 million for the 3 months ended June 30, $10 million up from their 2014 2nd quarter numbers. The company reported 81.7% higher losses, but grew revenue 22.9% compared to the […]